Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems.
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy in North America, underscoring the need for the development of new therapeutic strategies for the management of this disease. Although many drugs are pre-clinically tested every year, only a few are selected to be evaluated in...
Main Authors: | Bishnubrata Patra, Muhammad Abdul Lateef, Melica Nourmoussavi Brodeur, Hubert Fleury, Euridice Carmona, Benjamin Péant, Diane Provencher, Anne-Marie Mes-Masson, Thomas Gervais |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244549 |
Similar Items
-
Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
by: Melica Nourmoussavi Brodeur, et al.
Published: (2021-09-01) -
Predictive carboplatin treatment response models for epithelial ovarian cancer : comparison of 2D, 3D and in-vivo models
by: Brodeur, Melica
Published: (2021) -
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
by: Paule Héléna Yoffou, et al.
Published: (2011-01-01) -
Ran GTPase: A Key Player in Tumor Progression and Metastasis
by: Zied Boudhraa, et al.
Published: (2020-05-01) -
Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
by: Kossay Zaoui, et al.
Published: (2019-06-01)